Register information Patent

DE file number : 60 2011 064 378.9 (Status: pending/in force, Query started: May 21, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2011 064 378.9
96EP file numberEAKZ11 78 1973.0
86WO file numberWAKZPCT/US2011/059233
97EP publication numberEPN2635677
87WO publication numberWPN2012061654
54Designation/titleTIMODIFIZIERTE FACTOR IX PROTEINE UND DEREN VERWENDUNG
51IPC main classICM
(ICMV)
C12N 9/64 (2006.01)
22DE application dateDATNov 3, 2011
96EP application dateEATNov 3, 2011
86WO application dateWATNov 3, 2011
43Date of first publicationOTMay 10, 2012
Date of publication of grantPETJan 1, 2020
71/73Applicant/ownerINHGC Biopharma Corp., Yongin-si, Gyeonggi-do, KR
72InventorINMADISON, Edwin, L., San Francisco CA 94121, US; THANOS, Christopher, Tiburon CA 94920, US; BLOUSE, Grant, Ellsworth, Copenhagen S 2300, DK
Address for service Weickmann & Weickmann Patent- und Rechtsanwälte PartmbB, 81635 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
456298 P
Nov 3, 2010
Due dateFT
FG
Nov 30, 2024
Annual fee for the 14th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000002635677
Searchable text: EP000002635677
Original document: EP000002635677B1
Searchable text: EP000002635677B1
Original document: WO002012061654
Searchable text: WO002012061654
43Date of first publicationEVTMay 10, 2012
Date of the first transfer into DPMAregisterEREGTOct 25, 2013
Date of the (most recent) update in DPMAregisterREGTApr 15, 2025
(Show all update days)(Hide all update days)
  • Apr 15, 2025
    • Procedures: Procedure relating to EP application, EPO publication of mention of grant , 01.01.2020: new
    • Procedures: Procedure relating to EP application, EPO publication of mention of grant , 01.01.2020: deleted
  • Dec 11, 2024
    • Procedures: Procedure relating to PCT application, Publication of PCT application, 10.05.2012: deleted
  • Sep 16, 2023; May 25, 2023; Apr 19, 2023; Mar 7, 2023; Nov 26, 2021; Nov 28, 2020; Nov 19, 2020; Mar 16, 2020; Jan 23, 2020; Dec 17, 2019; Dec 12, 2019; Aug 21, 2019; Jul 11, 2019; Apr 25, 2019
    • Historical data not available for this/these date(s)
  • Oct 25, 2013
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to PCT application WO publication May 10, 2012  Details anzeigen
2 Procedure relating to EP application EPO 1st publication Sep 11, 2013  Details anzeigen
3 Publications Publication of a mention regarding EP 1st publication by DPMA Oct 24, 2013 Oct 24, 2013 Details anzeigen
4 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Jan 1, 2020  Details anzeigen
5 Publications Publication by DPMA of mention regarding EP patent grant Jan 23, 2020 Jan 23, 2020 Details anzeigen
6 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision Oct 2, 2020 Dec 24, 2020 Details anzeigen
7 New applicant/owner details New applicant/owner details Apr 18, 2023 May 25, 2023 Details anzeigen
View procedures Procedure relating to PCT application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to PCT application
Legal/procedural statusVSTWO publication
Date of legal/procedural statusVSTTMay 10, 2012
View procedures Procedure relating to EP application (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTSep 11, 2013
View procedures Publications (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTOct 24, 2013
Issue numberHN43
YearPJ2013
Publication dateVTOct 24, 2013
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTJan 1, 2020
Date of update of the procedureREGTApr 15, 2025
View procedures Publications (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTJan 23, 2020
Issue numberHN4
YearPJ2020
Publication dateVTJan 23, 2020
Type of publicationPARTBibliographic data
PartHTPart 5
View procedures Procedure relating to EP application (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTOct 2, 2020
Issue numberHN52
YearPJ2020
Publication dateVTDec 24, 2020
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTNov 28, 2020
View procedures New applicant/owner details (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTApr 18, 2023
Issue numberHN21
YearPJ2023
Publication dateVTMay 25, 2023
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHGC Biopharma Corp., Yongin-si, Gyeonggi-do, KR
71/73Previous applicant/ownerINHFCatalyst Biosciences, Inc., South San Francisco, Calif., US
Date of update of the procedureREGTMay 25, 2023